Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 25

Atrial Fibrillation", Eur Heart J, 31, pp. 967 ­ 975.

52. Friedman P., Gurevitz O. (2002), "Pulmonary Vein Exit­Block During Radio­Frequency Ablation of Paroxysmal Atrial Fibrillation", Circulation, 105, pp. e124 ­ e125.

53. Fuster V., Rydén L., Cannom D., et al. (2006), "ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines", Europace, 8 (9), pp. 651 ­ 745.

54. Fuster V., Rydén L., Cannom D., et al. (2006), "ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation­ executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines", J Am Coll Cardiol, 48 (4), pp. 854 ­ 906.

55. Gaita F., Riccardi R., Calo L., et al. (1998), "Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results.", Circulation, 97 (21), pp. 2136 ­ 2145.

56. Gaztanaga L., Frankel D., Kohari M., et al. (2013), "Time to recurrence of atrial fibrillation influences outcome following catheter ablation", Heart rhythm, 10 (1), pp. 2 ­ 9.

57. Go A., Hylek E., Chang Y., et al. (2003), "Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials

translate into clinical practice? ", JAMA, 290, pp. 2685 ­ 2692.

Có thể bạn quan tâm!

• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 22
• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 23
• Trần Văn Đồng (2006), Nghiên Cứu Điện Sinh Lý Tim Và Điều Trị Hội Chứng Wolff ­ Parkinson ­ White Bằng Năng Lượng Sóng Có Tần Số Radio, Luận Án Tiến Sĩ Y
• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 26
• Nghiên cứu đặc điểm điện sinh lý tim và kết quả điều trị cơn rung nhĩ kịch phát bằng năng lượng sóng có tần số radio - 27

Xem toàn bộ 224 trang tài liệu này.

58. Go A., Hylek E., Phillips K., et al. (2001), "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study", JAMA, 285 pp. 2370 ­ 2375.

59. Golden K., Mounsey J., Chung E., et al. (2012), "Atrial fibrillation ablation using a closed irrigation radiofrequency ablation catheter", PACE, 35 (5), pp. 506 ­ 516.

60. American Diabetes Association guidelines (2008), Guidelines and Protocols Diabetes care, British Columbia Medical publication.

61. Haissaguerre M., Jais P., Dipen C., et al. (2000), "Electro­ physiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci", Circulation, 101 (12), pp. 1409 ­ 1417.

62. Haissaguerre M., Jais P., Dipen C., et al. (1998), "Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins", N Engl J Med, 339, pp. 659 ­ 666.

63. Hassink R., Aretz T., Ruskin J., et al. (2003), "Morphology of atrial myocardium in human pulmonary veins. A postmortem analysis in patients with and without atrial fibrillation", J Am Coll Cardiol, 42 (6), pp. 108 ­ 114.

64. Heeringa J., Kuip D., Hofman A., et al. (2006), "Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study", Eur Heart J, 27, pp. 949 ­ 953.

65. Hindricks G., Piorkowski C., Tanner H., et al. (2005), "Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence", Circulation, 112, pp. 307 ­ 313.

66. Ho S., Cabrera J., Tran V., et al. (2001), "Architecture of the pulmonary veins: relevance to radiofrequency ablation", Heart, 86 (3), pp. 265 ­ 270.

67. Ho S., McCarthy K. (2010), "Anatomy of the left atrium for interventional electrophysiologists.", Pacing Clin Electrophysiol, 33 (5), pp. 620 ­ 627.

68. Hocini M., Jaïs P., Sanders P., et al. (2005), "Techniques, Evaluation, and Consequences of Linear Block at the Left Atrial Roof in Paroxysmal Atrial Fibrillation: A Prospective Randomized Study", Circulation, 112, pp. 3688 ­ 3696.

69. Hsu L., Jais P., Sanders P., et al. (2004), "Catheter ablation for atrial fibrillation in congestive heart failure", N Engl J Med, 351, pp. 2373 ­ 2383.

70. Hwang E., Nam G., Joung B., et al. (2012), "Significant reduction of atrial defibrillation threshold and inducibility by catheter ablation of atrial fibrillation", PACE, 35 (12), pp. 1428 ­ 1435.

71. Isabelle N., Miyazaki S., Forclaz A., et al. (2010), "Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation", Euro Heart Journal, 31, pp. 1046 ­ 1054.

72. Jais P., Cauchemez B., Macle L., et al. (2008), "Catheter ablation

versus antiarrhythmic drugs for atrial fibrillation: the A4 study",

Circulation, 118, pp. 2498 ­ 2505.

73. Jais P., Hocini M., Macle L., et al. (2002), "Distinctive electro­ physiological properties of pulmonary veins in patients with atrial fibrillation", Circulation, 106 (19), pp. 2479 ­ 2485.

74. Jongnarangsin K., Suwanagool A., Chugh A., et al. (2012), "Effect of catheter ablation on progression of paroxysmal atrial fibrillation", Journal of cardiovascular electrophysiology, 23 (1), pp. 9­14.

75. Jons C., Hansen P., Johannessen A., et al. (2009), "The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA­PAF) trial: clinical rationale, study design, and implementation.", Europace, 11 (7), pp. 917 ­ 923.

76. Khan M., Jais P., Cummings J., et al. (2008), "Pulmonary­vein isolation for atrial fibrillation in patients with heart failure", N Engl J Med, 359, pp. 1778 ­ 1785.

77. Khaykin Y., Marrouche N., Martin D., et al. (2004), "Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses.", J Cardiovasc Electrophysiol, 15 (7), pp. 784 ­ 789.

78. Khaykin Y., Wang X., Natale A., et al. (2009), "Cost comparison of ablation versus antiarrhythmic drugs as first­line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study", J Cardiovasc Electrophysiol, 20 (1), pp. 7­12.

79. Kistler P., Sanders P., Fynn S., et al. (2004), "Electrophysiologic and electroanatomic changes in the human atrium associated with age", J Am Coll Cardiol, 44 (1), pp. 109 ­ 116.

80. Kritz H., Schmid P., Sinzinger H. (1995), "Passive smoking and

cardiovascular risk ", Arch Intern Med, 155 (18), pp. 1942 ­ 1948.

81. Lall S., Melby S., Voeller R., et al. (2007), "The effect of ablation technology on surgical outcomes after the Cox­maze procedure: a propensity analysis", The Journal of thoracic and cardiovascular surgery, 133 (2), pp. 389 ­ 396.

82. Lamas G., Lee K., Sweeney M., et al. (2000), "The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients", Am Heart J, 140 (4), pp. 541 ­

551.

83. Lee J., Kalman J., (2013), "Sinus node dysfunction and atrial fibrillation: two sides of the same coin?", Europace, 15 (2), pp. 161 ­ 162.

84. Lip Y., Golding D., Nazir M., et al. (1997), "A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project", Br J Gen Pract, 47, pp. 285­289.

85. Lip Y., LI H. (2001), "Paroxysmal atrial Fibrillation", QJ Med, 94, pp. 665 ­ 678.

86. Lloyd­Jones D., Wang T., Leip E., et al. (2004), "Lifetime risk for development of atrial fibrillation: the Framingham Heart Study", Circulation, 110, pp. 1042 ­ 1046.

87. Mandapati R., Skanes A., Chen J., et al. (2000), "Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart", Circulation, 101 (2), pp. 194 ­ 199.

88. Markides V., Shilling R., Ho S., et al. (2003), "Characterization of the left atrial activation in the intact human heart", Circulation, 107, pp. 733 ­ 739.

89. Markides V., Schilling R. (2003), "Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment.", Heart, 89 (8), pp. 939 ­ 943.

90. Masateru T., Takahashi A., Kuwahara T. et al. (2014), "Long­Term Follow­Up After Catheter Ablation of Paroxysmal Atrial Fibrillation: The Incidence of Recurrence and Progression of Atrial Fibrillation", Circ Arrhythm Electrophysiol, 7, pp. 267 ­ 273.

91. Miao C., Yin X., Dong J., et al. (2012), "Catheter ablation of persistent atrial fibrillation with and without a history of paroxysmal atrial fibrillation", Chinese medical journal, 125(6), pp. 1175 ­ 1178.

92. Miyazaki S., Kuwahara T., Takahashi A. (2012), "Impact of the preprocedural frequency of paroxysmal atrial fibrillation on the clinical outcome after catheter ablation", PACE, 35 (10), pp. 1236 ­ 1241.

93. Mulder A., Wijffels M., Wever E., et al. (2012), "Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter­phased radiofrequency energy: 2­year follow­up and predictors of failure", Europace, 14 (6), pp. 818 ­ 825.

94. Murgatroyd F., Klein G., Yee R., et al. (2006), Handbook of Cardiac Electrophysiology. Re Medica publication.

95. Naccarelli G., Varker H., Lin J., et al. (2009), "Increasing prevalence of atrial fibrillation and flutter in the United States", Am J Cardiol, 104, pp. 1534 ­ 1539.

96. Nademanee K., McKenzie J., Kosar E., et al. (2004), "A new approach for catheter ablation of atrial fibrillation: mapping of the

electrophysiological substrate", J Am Coll Cardiol, 43 (11), pp. 2044 ­ 2053.

97. Nakao K., Seto S., Ueyama C., et al. (2002), "Extended distribution of prolonged and fractionated right atrial electrograms predicts development of chronic atrial fibrillation in patients with idiopathic paroxysmal atrial fibrillation", J Cardiovasc Electrophysiol, 13 (10), pp. 996 ­ 1002.

98. O’Donnell D., Furniss S. (2002), "Paroxysmal cycle length shortening in the pulmonary veins during atrial fibrillation correlates with arrhythmogenic triggering foci in sinus rhythm", J Cardiovasc Electrophysiol, 13 (2), pp. 124 ­ 128.

99. Olshansky B., Rosenfeld L., Warner A., et al. (2004), "The Atrial Fibrillation Follow­up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation", J Am Coll Cardiol, 43 (7), pp. 1201 ­ 1208.

100. Oral H., Ozaydin M., Chugh A., et al. (2003), "Role of the coronary sinus in maintenance of atrial fibrillation", Cardiovasc Electrophysiol, 14 (12), pp. 1329 ­ 1336.

101. Oral H., Sharf C., Chugh A., et al. (2003), "Catheter ablation for paroxysmal atrial fibrillation. Segmental pulmonary vein ostial ablation versus left atrial ablation", Circulation, 108, pp. 2355 ­ 2360.

102. Oral H., Aman C., Good E., et al. (2006), "A Tailored Approach to Catheter Ablation of Paroxysmal Atrial Fibrillation", Circulation, 113, pp. 1824 ­ 1831.

103. Oral H., Chugh A., Lemola K., et al. (2004), "Noninducibility of Atrial Fibrillation as an End Point of Left Atrial Circumferential Ablation for Paroxysmal Atrial Fibrillation: A Randomized Study",

Circulation, 110, pp. 2797 ­ 2801.

104. Oral H., Knight B., Tada H., et al. (2002), "Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation", Circulation, 105, pp. 1077 ­ 1081.

105. Ouyang F., Bansch D., Ernst S., et al. (2004), "Complete isolation of left atrium surrounding the pulmonary veins. New insights from the double­lasso technique in paroxysmal atrial fibrillation", Circulation, 110 pp. 2090 ­ 2096.

106. Pappone C., Augello G., Sala S., et al. (2006), "A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study", J Am Coll Cardiol, 48, pp. 2340 ­ 2347.

107. Pappone C., Santinelli V., Manguso F., et al. (2004), "Pulmonary vein denervation enhances long­term benefit after circumferential ablation for paroxysmal atrial fibrillation", Circulation, 109, pp. 327 ­ 334.

108. Pappone C., Oreto G., Lamberti F., et al. (1999), "Catheter Ablation of Paroxysmal Atrial Fibrillation Using a 3D Mapping System", Circulation, 100, pp. 1203 ­ 1208.

109. Pappone C., Rosanio S., Oreto G., et al. (2000), "Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation", Circulation 102, pp. 2619 ­ 2628.

110. Park Y., Choi J., Lim H., et al. (2012), "Is pursuit of termination of atrial fibrillation during catheter ablation of great value in patients with longstanding persistent atrial fibrillation?", Journal of cardiovascular electrophysiology, 23 (10), pp. 1051­ 1058.

111. Piccini J., Lopes R., Kong M., et al. (2009), "Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial